Capabilities at our facilities
We operate from state-of-the-art manufacturing and clinical facilities in the U.S. and U.K. Learn about our capabilities.
Our facilities include two clinical pharmacology units, two purpose-built pharmaceutical development and manufacturing sites. We support you by working under FDA or MHRA guidelines and offer a full range of support services, from study setup through to data analysis and reporting.
Global formulation and manufacturing
- Pharmaceutical development and manufacturing facilities in the U.S. and U.K.
- Production of Phase I – Phase III clinical drug supplies
- Commercial product manufacture for solid dosage forms and liquid formats
- U.S. facility is FDA / EMA / PMDA approved, U.K. facility is MHRA approved
- GMP manufacturing suites globally including high potent compound handling
- Scalable manufacturing equipment for non-sterile dosage forms
- Batch sizes ranging from small scale (200g) to large scale (500kg) for tablet and capsule drug products and up to 350L for liquid presentations
- Clinical packaging, labeling and global distribution for Phase I – Phase IIb programs
Global clinical pharmacology
- Two purpose built Phase I units in the U.S. (Miami) and U.K. (Nottingham)
- >245 bed capacity across Miami (U.S.), and Nottingham (U.K.)
- Experienced team of 16 physicians and principal investigators
- >1,300 Phase I studies completed to date
- Database of >25,000 active participants across a broad demographic
- Medical writing, data management, pharmacokinetics, statistical analysis and reporting
Contact
Get in touch with us
-
LocationsOur LocationsGet in touch and discover how Quotient Sciences can help you accelerate your drug development timeline and reduce your costs.
-
Contact usAsk the ExpertsWe can help you with any of your drug development challenges. Ask our experts a question. Our scientific team is ready to help.
Ready to get started?
Share your project needs with us.